Document Detail


Therapies for acute heart failure in patients with reduced kidney function: a community-based perspective.
MedLine Citation:
PMID:  18371535     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Limited data exist describing the management of patients with decreased kidney function at the time of hospital presentation for acute heart failure (HF).
STUDY DESIGN: Nonconcurrent prospective study.
SETTING & PARTICIPANTS: Patients hospitalized with clinical findings of decompensated HF (n = 4,350) at all 11 greater Worcester, MA, medical centers in 1995 and 2000. Patients were categorized into varying levels of kidney function based on their estimated glomerular filtration rate (eGFR).
PREDICTOR: GFR estimates from serum creatinine levels measured at the time of hospital admission.
OUTCOMES: Hospital receipt of angiotensin-converting enzyme (ACE) inhibitors/angiotensin receptor blockers (ARBs), beta-blockers, digoxin, and diuretics.
MEASUREMENTS: Hospital charts were reviewed for prescribing of disease-modifying cardiac therapies, as well as therapies designed to provide symptomatic relief from HF.
RESULTS: Average eGFR in our study sample was 64.4 +/- 33.1 mL/min/1.73 m(2), and patients were categorized further into 3 eGFR levels of less than 30 (n = 569), 30 to 59 (n = 1,488), and 60 mL/min/1.73 m(2) or greater (n = 2,293) for comparative purposes. Patients with greater eGFRs (>or=60 mL/min/1.73 m(2)) were more likely to be treated with ACE inhibitors/ARBs (56% versus 39%) and digoxin (51% versus 46%) during hospitalization for HF than patients with lower eGFRs (<30 mL/min/1.73 m(2); P < 0.05). Patients with lower eGFRs (<30 mL/min/1.73 m(2)) were more likely to be prescribed beta-blockers than patients with greater eGFRs (>or=60 mL/min/1.73 m(2); 46% versus 39%; P < 0.01). Use of ACE inhibitors/ARBs increased between 1995 and 2000 in 2 of the 3 eGFR groups examined: eGFRs less than 30 mL/min/1.73 m(2) (33% in 1995; 42% in 2000) and eGFRs of 60 mL/min/1.73 m(2) or greater (51% in 1995; 59% in 2000). Use of beta-blockers increased appreciably in all 3 eGFR groups (<30 mL/min/1.73 m(2), 27% in 1995; 58% in 2000; >or=60 mL/min/1.73 m(2): 25% in 1995; 49% in 2000). However, less than one third of all patients were treated with both disease-modifying therapies in 2000.
LIMITATIONS: We were unable to classify patients into those with systolic versus diastolic HF.
CONCLUSIONS: Our results suggest that use of disease-modifying therapies for patients hospitalized with clinical findings of acute HF and decreased kidney function remains less than desirable. Educational programs are needed to enhance the management of patients with decreased kidney function who develop HF.
Authors:
Robert J Goldberg; Rovshan M Ismailov; Vishnu Patlolla; Darleen Lessard; Frederick A Spencer
Related Documents :
9200765 - Special considerations for monitoring vancomycin concentrations in pediatric patients.
20428005 - Use of brain natriuretic peptide and bioimpedance to guide therapy in heart failure pat...
12372945 - Increased circulating levels of natriuretic peptides predict future cardiac event in pa...
15012715 - Osteodystrophy in indonesian haemodialysis patients.
22348415 - Association between hla-b*58:01 allele and severe cutaneous adverse reactions with allo...
15277735 - Heart rate variability and ambulatory blood pressure monitoring in young patients with ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2008-02-07
Journal Detail:
Title:  American journal of kidney diseases : the official journal of the National Kidney Foundation     Volume:  51     ISSN:  1523-6838     ISO Abbreviation:  Am. J. Kidney Dis.     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-03-28     Completed Date:  2008-05-28     Revised Date:  2014-09-15    
Medline Journal Info:
Nlm Unique ID:  8110075     Medline TA:  Am J Kidney Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  594-602     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Aged
Female
Glomerular Filtration Rate
Heart Failure / drug therapy*
Humans
Kidney / physiopathology*
Male
Prospective Studies
Grant Support
ID/Acronym/Agency:
R37 HL069874/HL/NHLBI NIH HHS; R37 HL069874-06/HL/NHLBI NIH HHS; R37 HL69874/HL/NHLBI NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Kidney function and progression of carotid intima-media thickness in a community study.
Next Document:  Differential expression of proteins from cultured endothelial cells exposed to uremic versus normal ...